![shutterstock_2437562597 3](http://www.ia-grp.com/wp-content/uploads/2024/03/shutterstock_2437562597-3-scaled.jpg)
![](http://www.ia-grp.com/wp-content/uploads/2017/07/ORANGE-SLIDER-SHAPE-1.1.png)
NEWS
IAG Strengthens its Leadership Team
IAG names Roughan Sheedy CEO Seasoned Technology Leader to Drive Growth and Innovation at Leading Image Analysis Group. 8 February 2024, London – Image Analysis Group (IAG), a leading provider of image analysis solutions for the biotechnology and pharmaceutical industries, today announced the appointment of Roughan Sheedy as Chief Executive Officer. Dr. Olga Kubassova, IAG’s founder …
9 Abstracts Accepted for Presentation in Rheumatology and Oncology Upcoming Meetings
Nine IAG's abstracts, reflecting clinical research innovations of the past year, were accepted for presentation in the industry’s leading #rheumatology and #oncology scientific meetings. In the next 3 months, IAG’s scientific team will present our scientific work in inflammatory arthritis, osteoarthritis, degenerative and genetic muscle diseases, scleroderma, rare musculoskeletal diseases at European League Against Rheumatism …
IAG Accelerates Growth with Opening of New Office in Philadelphia, USA
We are delighted to announce the opening of our new office in Philadelphia, PA, USA. This location has a long history of pharmaceutical and biotechnology innovation, bringing together 5 children’s hospitals, 4 national cancer centres, 126 hospitals and many global industry leaders and start-up companies. We are excited to carry on this tradition and to …
IAG Joins Forces with ImageBiopsy Lab to Bring New Machine Learning Tools for Osteoarthritis Clinical Research
We are pleased to announce IAG’ commitment to invest into further development of machine learning approaches, critical for #osteoarthritis clinical research. IAG will closely work with the innovative healthcare-focused artificial intelligent company ImageBiopsy Lab to bring advanced tools for automated processing of X-ray imaging and extraction of quantitative biomarkers, which are much needed in osteoarthritis …
Artificial Intellegence and Data Science Showcase, IAG’s team are presenting at Precision Medicine World Conference, SFO, USA, Jan 22-24, 2018
Javier Gonzales, Head of Experimental Imaging at IAG will present at Precision Medicine World Conference 2018 on the topic of using artificial intelligence, machine learning and cloud based platforms in supporting clinical research and clinical practise decisions: AI and Data Science Showcase: AI Hospital for Patients Medical Imaging Data. To attend the talk: Day 1, 1:45 (track …
Novel Early Response Biomarkers for Renal Cell Carcinoma – New Data Is Presented at RSNA Meeting, 29 Nov-1 Dec 2017, Chicago, USA
IAG is to present at annual meeting of the Radiological Society of North America (RSNA) their latest scientific work in advanced quantitative image analysis in renal cell carcinoma (RCC) in collaboration with the Peter MacCallum Cancer Center, Melbourne, Australia. The developed multi-parametric MRI analysis methodology including DCE-MRI revealed RCC treatment efficacy where RECIST-based approaches are …
DYNAMIKA improves speed and accuracy of breast MRI analysis – presentation at ESMRMB 2017 Congress, 19-21 Oct 2017
Breast cancer is the second most common cancer overall and the most common cancer in woman worldwide. MRI is the most sensitive imaging technique for cancer detection. Women with very high risk for cancer are currently recommended for cancer screening with magnetic resonance imaging (MRI). MRI also plays a critical role in lesion characterization and …
New England Journal of Medicine Publishes the Results of the Trial in Patients with Acute Muscle Injury
Skeletal muscle injuries present a challenge in primary care and sports medicine. This is a fast-growing market with a number of bio-pharma companies developing new treatment to reduce inflammation, to enhance injury healing and reduce a player's injury time. The global sports medicine market is projected to reach USD 8.24b by 2022 from USD 5.78 …